Get started
Fulgent Genetics, Inc.Fulgent Genetics, Inc.Fulgent Genetics, Inc.

Fulgent Genetics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

FLGT chart


Full chart

FLGT upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪588.66 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−5.53 USD
Net income (FY)
‪−167.82 M‬ USD
Revenue (FY)
‪289.21 M‬ USD
Shares float
‪19.74 M‬
Beta (1Y)
−0.25

Employees


Employees (FY)
‪1.18 K‬
Change (1Y)
+172 +17.00%
Revenue / Employee (1Y)
‪244.27 K‬ USD
Net income / Employee (1Y)
‪−141.74 K‬ USD

About Fulgent Genetics, Inc.


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Ming Hsieh
Website
fulgentgenetics.com
Headquarters
El Monte
Founded
2016
FIGI
BBG00DR7LTG2
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

FLGT news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of FLGT is 19.43 USD — it has decreased by −11.76% in the past 24 hours. Watch Fulgent Genetics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Fulgent Genetics, Inc. stocks are traded under the ticker FLGT.
FLGT stock has fallen by −9.50% compared to the previous week, the month change is a −4.99% fall, over the last year Fulgent Genetics, Inc. has showed a −26.51% decrease.
We've gathered analysts' opinions on Fulgent Genetics, Inc. future price: according to them, FLGT price has a max estimate of 30.00 USD and a min estimate of 26.00 USD. Watch FLGT chart and read a more detailed Fulgent Genetics, Inc. stock forecast: see what analysts think of Fulgent Genetics, Inc. and suggest that you do with its stocks.
FLGT reached its all-time high on Feb 9, 2021 with the price of 189.89 USD, and its all-time low was 2.73 USD and was reached on Nov 7, 2017. View more price dynamics on FLGT chart.
See other stocks reaching their highest and lowest prices.
FLGT stock is 16.14% volatile and has beta coefficient of −0.25. Track Fulgent Genetics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Fulgent Genetics, Inc. there?
Today Fulgent Genetics, Inc. has the market capitalization of ‪588.66 M‬, it has increased by 5.85% over the last week.
Yes, you can track Fulgent Genetics, Inc. financials in yearly and quarterly reports right on TradingView.
Fulgent Genetics, Inc. is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
FLGT earnings for the last quarter are 0.31 USD per share, whereas the estimation was −0.15 USD resulting in a 301.52% surprise. The estimated earnings for the next quarter are −0.39 USD per share. See more details about Fulgent Genetics, Inc. earnings.
Fulgent Genetics, Inc. revenue for the last quarter amounts to ‪71.74 M‬ USD, despite the estimated figure of ‪71.72 M‬ USD. In the next quarter, revenue is expected to reach ‪74.87 M‬ USD.
FLGT net income for the last quarter is ‪−14.65 M‬ USD, while the quarter before that showed ‪−8.71 M‬ USD of net income which accounts for −68.17% change. Track more Fulgent Genetics, Inc. financial stats to get the full picture.
No, FLGT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has ‪1.18 K‬ employees. See our rating of the largest employees — is Fulgent Genetics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Fulgent Genetics, Inc. EBITDA is ‪−63.40 M‬ USD, and current EBITDA margin is −15.05%. See more stats in Fulgent Genetics, Inc. financial statements.
Like other stocks, FLGT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Fulgent Genetics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Fulgent Genetics, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Fulgent Genetics, Inc. stock shows the sell signal. See more of Fulgent Genetics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.